Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms.

Abstract:

:Tumorigenesis can be considered as pathologically misappropriated tissue regeneration. In this review we will address some unresolved issues that support this concept. First, we will address the issue of the identity of cancer-initiating cells and the presence of cancer stem cells in growing tumors. We will also ask are there rare and distinct populations of cancer stem cells in established tumor cell lines, or are all of the cells cancer stem cells? Second, the most important clinical problem with cancer is its metastasis, and here a challenging question arises: by employing radio-chemotherapy for tumor treatment, do we unintentionally create a prometastatic microenvironment in collateral organs? Specifically, many factors upregulated in response to radio-chemotherapy-induced injury may attract highly migratory cancer cells that survived initial treatment. Third, what is the contribution of normal circulating stem cells to the growing malignancy? Do circulating normal stem cells recognize a tumor as a hypoxia-damaged tissue that needs vascular and stromal support and thereby contribute to tumor expansion? Fourth, is it reasonable to inhibit only one prometastatic ligand-receptor axis when cancer stem cells express several receptors for several chemotactic factors that may compensate for inhibition of the targeted receptor? Fifth, since most aggressive cancer cells mimic early-development stem cells, which properties of embryonic stem cells are retained in cancer cells? Would it be reasonable to inhibit cancer cell signaling pathways involved in the migration and proliferation of embryonic stem cells? We will also briefly address some new players in cancerogenesis, including extracellular microvesicles, bioactive phospholipids, and extracellular nucleotides.

journal_name

Leukemia

journal_title

Leukemia

authors

Ratajczak MZ,Bujko K,Mack A,Kucia M,Ratajczak J

doi

10.1038/s41375-018-0294-7

subject

Has Abstract

pub_date

2018-12-01 00:00:00

pages

2519-2526

issue

12

eissn

0887-6924

issn

1476-5551

pii

10.1038/s41375-018-0294-7

journal_volume

32

pub_type

杂志文章,评审

相关文献

LEUKEMIA文献大全
  • Nine years' experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group report.

    abstract::One-hundred, twenty-eight patients with Hodgkin's disease in remission or who had failed a mechlorethamine, vincristine, procarbazine and prednisone (MOPP), a doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) and/or lomustine, etoposide and prednimustine (CEP) regimens have been treated with a high-dose thera...

    journal_title:Leukemia

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Carella Am,Carlier P,Congiu A,Occhini D,Meloni G,Anselmo AP,Mandelli F,Mazza P,Tura S,Mangoni L

    更新日期:1991-01-01 00:00:00

  • Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).

    abstract::p53 is frequently wild type (wt) in diffuse large B-cell lymphoma (DLBCL) associated with t(14;18)(q32;q21) that overexpresses BCL2. Nutlin-3a is a small molecule that activates the p53 pathway by disrupting p53-MDM2 interaction. We show that nutlin-3a activates p53 in DLBCL cells associated with t(14;18)(q32;q21), BC...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:10.1038/leu.2011.28

    authors: Drakos E,Singh RR,Rassidakis GZ,Schlette E,Li J,Claret FX,Ford RJ Jr,Vega F,Medeiros LJ

    更新日期:2011-05-01 00:00:00

  • FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.

    abstract::The FOXP1 (forkhead box P1) transcription factor is a marker of poor prognosis in diffuse large B-cell lymphoma (DLBCL). Here microarray analysis of FOXP1-silenced DLBCL cell lines identified differential regulation of immune response signatures and major histocompatibility complex class II (MHC II) genes as some of t...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:10.1038/leu.2015.299

    authors: Brown PJ,Wong KK,Felce SL,Lyne L,Spearman H,Soilleux EJ,Pedersen LM,Møller MB,Green TM,Gascoyne DM,Banham AH

    更新日期:2016-03-01 00:00:00

  • Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia.

    abstract::Thiopurine methyltransferase (TPMT) catalyses the S-methylation of thiopurines, including 6-mercaptopurine and 6-thioguanine. TPMT activity exhibits genetic polymorphism, with about 1/300 inheriting TPMT deficiency as an autosomal recessive trait. If treated with standard doses of thiopurines, TPMTdeficient patients a...

    journal_title:Leukemia

    pub_type: 杂志文章,评审

    doi:10.1038/sj.leu.2401723

    authors: McLeod HL,Krynetski EY,Relling MV,Evans WE

    更新日期:2000-04-01 00:00:00

  • Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes.

    abstract::Human T cell leukemia virus type-I (HTLV-I), the etiologic agent of adult T cell leukemia (ATL) transforms human T cells in vitro and in vivo. Tax, the major transactivator of HTLV-I is critical for the initial events involved in transformation, however, the later steps required for progression from an IL-2 dependent ...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Gartenhaus RB,Wang P

    更新日期:1995-12-01 00:00:00

  • Translocation t(9;11)(p21;q23) in pediatric de novo and secondary acute myeloblastic leukemia.

    abstract::The t(9;11)(p21;q23) has been associated with characteristic clinical features and a superior treatment outcome in previously untreated pediatric acute myeloblastic leukemia (AML), but has not been well studied in children with secondary AML. This translocation was detected in 6.7% of de novo and 46% of secondary AML ...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Sandoval C,Head DR,Mirro J Jr,Behm FG,Ayers GD,Raimondi SC

    更新日期:1992-06-01 00:00:00

  • Interleukin-2 and antibody to the T cell receptor regulate proliferation of a radiation leukemia virus-transformed T cell lymphoma.

    abstract::In this report, a Radiation leukemia virus-transformed murine T cell lymphoma is described which is dependent on the interleukin-2 (IL-2) growth factor for proliferation under single cell conditions of growth. It was isolated from a C57BL mouse which had been primed with the Radiation leukemia virus-induced thymoma, C...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: O'Neill HC

    更新日期:1988-02-01 00:00:00

  • New structural chromosomal rearrangements in congenital leukemia.

    abstract::The karyotypic abnormalities and clinical data on three patients in whom acute leukemia was diagnosed within the first 6 months of life are presented. The four structural chromosomal rearrangements detected in the bone marrow from these patients, i.e., t(7;12)(q36;p13) and t(1;19)(q11;q11) in case 1, t(2;10;11;12)(q21...

    journal_title:Leukemia

    pub_type: 杂志文章,评审

    doi:

    authors: Heim S,Békàssy AN,Garwicz S,Heldrup J,Wiebe T,Kristoffersson U,Mandahl N,Mitelman F

    更新日期:1987-01-01 00:00:00

  • p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene.

    abstract::The p210 bcr-abl fusion protein tyrosine kinase oncogene has been implicated in the pathogenesis of chronic granulocytic leukemia (CGL). Specific intracellular functions performed by p210 bcr-abl have recently been delineated. We considered the possibility that p210 bcr-abl may also regulate the abundance of inosine 5...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Gharehbaghi K,Burgess GS,Collart FR,Litz-Jackson S,Huberman E,Jayaram HN,Boswell HS

    更新日期:1994-08-01 00:00:00

  • CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.

    abstract::The activation of natural killer (NK) cells leads to degranulation and secretion of cytotoxic granula. During this process, the lytic granule membrane protein CD107a becomes detectable at the cell surface. Based on this phenomenon, we have analyzed by a novel flow cytometry-based assay, the number and phenotype of NK ...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:10.1038/sj.leu.2403704

    authors: Penack O,Gentilini C,Fischer L,Asemissen AM,Scheibenbogen C,Thiel E,Uharek L

    更新日期:2005-05-01 00:00:00

  • Localization of the chromosome 15 breakpoints and expression of multiple PML-RAR alpha transcripts in acute promyelocytic leukemia: a study of 28 Chinese patients.

    abstract::Translocation (15;17)(q22;q12-q21) is a chromosome aberration specifically found in acute promyelocytic leukemia (APL), that generates a chimeric gene between the promyelocytic leukemia (PML) gene on chromosome 15 and the retinoic acid receptor alpha (RARA) gene, on chromosome 17. In the course of molecular investigat...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Geng JP,Tong JH,Dong S,Wang ZY,Chen SJ,Chen Z,Zelent A,Berger R,Larsen CJ

    更新日期:1993-01-01 00:00:00

  • Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif.

    abstract::NUP98 gene rearrangements occur in acute myeloid leukemia and result in the expression of fusion proteins. One of the most frequent is NUP98-DDX10 that fuses a portion of NUP98 to a portion of DDX10, a putative DEAD-box RNA helicase. Here, we show that NUP98-DDX10 dramatically increases proliferation and self-renewal ...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:10.1038/leu.2010.42

    authors: Yassin ER,Abdul-Nabi AM,Takeda A,Yaseen NR

    更新日期:2010-05-01 00:00:00

  • The human lysozyme gene undergoes stepwise demethylation during phagocyte maturation.

    abstract::The lysozyme (LZM) gene provides a very useful model for studies of phagocyte maturation, because its protein synthesis is increased during myelopoiesis and thus most abundant in terminally differentiated and activated phagoyctes. LZM gene expression and DNA methylation were examined in various normal and transformed ...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:10.1038/sj.leu.2400693

    authors: Lübbert M,Henschler R,Kreutz M,Andreesen R,Mertelsmann R,Herrmann F

    更新日期:1997-07-01 00:00:00

  • Down-regulation of c-myc gene is not obligatory for growth inhibition and differentiation of human myeloid leukemia cells.

    abstract::Suppression of c-myc expression is observed during induced differentiation of several myeloid cell lines and it has been attributed to the cell growth arrest that accompanies terminal differentiation. To dissect the role of c-Myc in the proliferation-differentiation switch we have studied c-myc expression in K562 cell...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Gómez-Casares MT,Delgado MD,Lerga A,Crespo P,Quincoces AF,Richard C,León J

    更新日期:1993-11-01 00:00:00

  • Contact inhibition-induced inactivation of the cyclin D-dependent kinase in rat fibroblast cell line, 3Y1.

    abstract::Inhibitory proteins for Cdks (CKIs) are involved in cell cycle arrest induced by anti-mitotic factors, chemicals, or DNA damage in mammalian cells. High cell density also induces cell cycle arrest with unreplicated genomic DNA even in the presence of mitotic dose of the growth factors, termed contact inhibition. Altho...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Kato A,Takahashi H,Takahashi Y,Matsushime H

    更新日期:1997-04-01 00:00:00

  • Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.

    abstract::We analyzed mRNA expression of the flt3 gene in 30 patients with acute myeloid leukemia (AML) and 50 with acute lymphoblastic leukemia (ALL). Using reverse transcriptase-polymerase chain reaction (RT-PCR), expression of flt3 was observed in 61 patients; 22 (73%) with AML and 39 (78%) with ALL. Among these, five patien...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Nakao M,Yokota S,Iwai T,Kaneko H,Horiike S,Kashima K,Sonoda Y,Fujimoto T,Misawa S

    更新日期:1996-12-01 00:00:00

  • Interleukin-6 autoantibodies: possible biological and clinical significance.

    abstract::The pleiotropic cytokines, interleukin (IL)-1 alpha, type I interferons and IL-6 also act on cells involved in antibody production. Somehow the immunologic tolerance to these cytokines is often spontaneously broken--even in healthy individuals. Thus, relatively high concentrations of high affinity IgG antibodies again...

    journal_title:Leukemia

    pub_type: 杂志文章,评审

    doi:

    authors: Hansen MB,Svenson M,Diamant M,Abell K,Bendtzen K

    更新日期:1995-07-01 00:00:00

  • Rapid positive selection of CD34+ cells using magnetic microspheres coated with monoclonal antibody QBEND/10 linked via a cleavable disulphide bond.

    abstract::Positive selection of CD34+ cells has applications in diagnostic pathology, in peripheral blood and bone marrow transplantation, and in studies on the function and regulation of primitive haemopoietic stem cells. Antibody-coated magnetic microspheres (dynabeads) can be used to isolate these cells by positive selection...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Grimsley PG,Amos TA,Gordon MY,Greaves MF

    更新日期:1993-06-01 00:00:00

  • Suppression of retroviral tumors in hosts immune to viral oncogene product.

    abstract::Feline sarcoma virus of Snyder-Theilen strain (ST-FeSV) induces sarcomas in Wistar/Ma rats following neonatal virus injection. Induced tumors express the viral oncogene product (P85) and elicit in hosts the specific serum anti-P85 antibody detectable by Western blot analysis. Syngeneic adult female rats were immunized...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Maruyama K,Miyauchi M,Mochizuki S,Fukushima T,Koshikawa N,Kawamura K,Awaya A,Kobayashi H

    更新日期:1994-04-01 00:00:00

  • The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.

    abstract::A monoclonal antibody (17F11) was raised by immunization of a Balb/c mouse with leukemic blasts from a patient with acute non-lymphocytic leukemia (ANLL). This antibody recognizes most leukemic blasts of myeloid but not of lymphoid lineage and no peripheral blood cells. By screening NIH-3T3 fibroblasts transfected wit...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Bühring HJ,Ullrich A,Schaudt K,Müller CA,Busch FW

    更新日期:1991-10-01 00:00:00

  • Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias.

    abstract::Activating mutations in NOTCH1 are found in over 50% of human T-cell lymphoblastic leukemias (T-ALLs). Here, we report the analysis for activating NOTCH1 mutations in a large number of acute myeloid leukemia (AML) primary samples and cell lines. We found activating mutations in NOTCH1 in a single M0 primary AML sample...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:10.1038/sj.leu.2404409

    authors: Palomero T,McKenna K,O-Neil J,Galinsky I,Stone R,Suzukawa K,Stiakaki E,Kalmanti M,Fox EA,Caligiuri MA,Aster JC,Look AT,Ferrando AA

    更新日期:2006-11-01 00:00:00

  • Alternative rearrangements of immunoglobulin light chain genes in human leukemia.

    abstract::Immunoglobulin heavy and light chain genes undergo rearrangement before they can be expressed by B-cells. A sequence of successive rearrangements has been proposed, suggesting that these events are initiated on heavy chain genes and are followed by sequential attempts of light chain gene rearrangements involving kappa...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Tang JQ,Béné MC,Faure GC

    更新日期:1991-08-01 00:00:00

  • Identification of T-cell epitopes for cancer immunotherapy.

    abstract::The effectiveness of T-cell-mediated immunotherapy of cancer depends on both an optimal immunostimulatory context of the therapy and the proper selection with respect to quality and quantity of the targeted tumor-associated antigens (TAA), and, more precisely, the T-cell epitopes contained in these tumor proteins. Our...

    journal_title:Leukemia

    pub_type: 杂志文章,评审

    doi:10.1038/sj.leu.2404787

    authors: Kessler JH,Melief CJ

    更新日期:2007-09-01 00:00:00

  • In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.

    abstract::Fludarabine phosphate (2-F-ara-AMP) is an adenine nucleoside analogue that shows significant activity against chronic lymphocytic leukemia and indolent lymphoma. We assessed the cytotoxic interaction produced by the combination of the active metabolite of fludarabine phosphate, fludarabine (9-beta-D-arabinofuranosyl-2...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:10.1038/sj.leu.2401684

    authors: Kano Y,Akutsu M,Tsunoda S,Suzuki K,Ichikawa A,Furukawa Y,Bai L,Kon K

    更新日期:2000-03-01 00:00:00

  • Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis.

    abstract::Conditionally replicating adenoviruses (CRAds) represent a promising new platform for anticancer therapy. However, CRAds have been evaluated little in hematopoietic malignancies because of the lack of expression of coxsackie adenovirus receptor (CAR) on their cell surface. In this study, we showed that CAR was express...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:10.1038/sj.leu.2405034

    authors: Qian W,Liu J,Tong Y,Yan S,Yang C,Yang M,Liu X

    更新日期:2008-02-01 00:00:00

  • Interleukin-4-mediated inhibition of C-Fos mRNA expression: role of the lipoxygenase directed pathway.

    abstract::Interleukin-4 inhibits several monocyte functions like A23187-induced expression of cytokines and c-fos and c-jun proto-oncogene mRNA expression. In an attempt to elucidate the mechanism by which this inhibitive effect is mediated, we compared the effect of IL-4 on A23187-induced c-fos and c-jun mRNA expression in con...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Dokter WH,Sierdsema SJ,Esselink MT,Halie MR,Vellenga E

    更新日期:1994-07-01 00:00:00

  • Increased resistance to methotrexate in human hematopoietic cells after gene transfer of the Ser31 DHFR mutant.

    abstract::Retroviral gene transfer into hematopoietic cells has many experimental as well as clinical applications. Although transduction efficiency of retroviral vectors is higher than with conventional methods, selection of successfully transduced cells may become mandatory for efficient in vivo transfer. We have been evaluat...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Flasshove M,Banerjee D,Bertino JR,Moore MA

    更新日期:1995-10-01 00:00:00

  • Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.

    abstract::Burkitt lymphoma (BL) has a characteristic clinical presentation, morphology, immunophenotype and primary chromosomal aberration, that is, the translocation t(8;14)(q24;q32) or its variants. However, diagnostic dilemmas may arise in daily practice due to overlap of BL with subsets of other aggressive, mature B-cell ly...

    journal_title:Leukemia

    pub_type: 历史文章,杂志文章,评审

    doi:10.1038/leu.2008.281

    authors: Boerma EG,Siebert R,Kluin PM,Baudis M

    更新日期:2009-02-01 00:00:00

  • The effect of epidermal growth factor receptor (EGFR) expression on in vivo growth of rat C6 glioma cells.

    abstract::The discovery of EGFR gene amplification in glioblastoma multiforme has prompted interest in experimental therapies to target the receptor on brain tumor cells. To develop an animal model for in vivo study of such strategies, we transfected C6 glioma cells with a plasmid containing the neomycin resistance gene and the...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Fenstermaker RA,Capala J,Barth RF,Hujer A,Kung HJ,Kaetzel DM Jr

    更新日期:1995-10-01 00:00:00

  • Effects of clinical combinations of antileukemic drugs on DNA ligase from human thymocytes and normal, stimulated, or leukemic lymphocytes.

    abstract::Human DNA ligase was purified from different kinds of immunocompetent cells: thymocytes, normal and stimulated lymphocytes, blasts from ALL (Burkitt and non-T, non-B) and ANLL (M1, M2, and M5). Based upon the protocol for the treatment of these leukemias, the purified enzymes were assayed in the presence of routinely ...

    journal_title:Leukemia

    pub_type: 杂志文章

    doi:

    authors: Lamballe F,Maniey D,Boscher MY,Fauchet R,le Prise PY,David JC

    更新日期:1988-06-01 00:00:00